Prosight Management’s Janux Therapeutics JANX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$19.7M	Buy	853,904 +164,003	+24%	+$3.79M	4.81%	8
2025 Q1	$18.6M	Buy	689,901 +360,133	+109%	+$9.72M	6.12%	4
2024 Q4	$17.7M	Buy	329,768 +124,768	+61%	+$6.68M	4.88%	10
2024 Q3	$9.31M	Buy	+205,000	New	+$9.31M	2.29%	19